Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study looks into cancer-related harmful communication.

2.

France Expands 2026 Vaccination Rules Amid Resurgence

3.

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

4.

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

5.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot